InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: jellybean post# 2971

Monday, 09/04/2006 6:37:33 PM

Monday, September 04, 2006 6:37:33 PM

Post# of 6489
Looking at Herceptin in comparison with INSM-18, they appear to block the same receptor, (Her2/neu) but INSM-18 inhibits what Herceptin plus BP3 inhibits. "INSM-18, a small molecule tyrosine kinase inhibitor, has demonstrated selective inhibition of the insulin-like growth factor-I receptor (IGF-I) and human epidermal growth factor receptor (Her2/neu)." Since I don't claim to understand all of the scientific data, could this be a valid assumption or could INSM-18 + BP3 be a viable compound?

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News